Julie VanOrsdel Daves
Net worth: - $ as of 2024-06-29
Career history of Julie VanOrsdel Daves
Former positions of Julie VanOrsdel Daves
| Companies | Position | Start | End |
|---|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | - | 2024-04-17 |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Corporate Officer/Principal | 2021-08-31 | 2022-07-31 |
| EDGEWISE THERAPEUTICS, INC. | Corporate Officer/Principal | 2018-01-31 | 2021-07-31 |
miRagen Therapeutics, Inc. /Old/
 miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology miRagen Therapeutics, Inc. develops microRNA-based therapeutics for cardiovascular and muscle diseases. It leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance RNA-based technologies and potential drug candidates for its own pipeline and in strategic collaborations. The firm aso focuses on hematological malignancies, fibrosis and neuro inflammation. The company was founded by William S. Marshall, Michael R. Bristow, Marvin H. Caruthers, Bruce Lee Booth and Eric Newell Olson in 2007 and is headquartered in Boulder, CO. | Corporate Officer/Principal | 2016-01-31 | 2018-01-31 |
Chiltern International, Inc.
 Chiltern International, Inc. BiotechnologyHealth Technology Part of Laboratory Corp. of America Holdings, Chiltern International, Inc. is a contract research organization that offers clinical development, scientific services, and collaborative technologies. | Corporate Officer/Principal | 2015-10-31 | 2016-01-31 |
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2007-03-31 | 2010-12-31 |
Training of Julie VanOrsdel Daves
| North Carolina State University | Undergraduate Degree |
| George Washington University School of Medicine & Health | Graduate Degree |
Statistics
International
| United States | 8 |
| Spain | 2 |
Operational
| Corporate Officer/Principal | 6 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| DIAMEDICA THERAPEUTICS INC. | Health Technology |
| EDGEWISE THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
miRagen Therapeutics, Inc. /Old/
miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology miRagen Therapeutics, Inc. develops microRNA-based therapeutics for cardiovascular and muscle diseases. It leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance RNA-based technologies and potential drug candidates for its own pipeline and in strategic collaborations. The firm aso focuses on hematological malignancies, fibrosis and neuro inflammation. The company was founded by William S. Marshall, Michael R. Bristow, Marvin H. Caruthers, Bruce Lee Booth and Eric Newell Olson in 2007 and is headquartered in Boulder, CO. | Health Technology |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Health Technology |
Chiltern International, Inc.
Chiltern International, Inc. BiotechnologyHealth Technology Part of Laboratory Corp. of America Holdings, Chiltern International, Inc. is a contract research organization that offers clinical development, scientific services, and collaborative technologies. | Health Technology |
